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ABSTRACT 
The aim of the present study was to prepare mouth dissolving tablets of Bambuterol hydrochloride by using pertinent disintegrants. The 
tablets were prepared using mannitol and lactose along with two levels of disintegrant by direct compression method. The superdisintegrants 
used in this study were croscamellose sodium (CCS) and sodium starch glycolate (SSG). The tablets were evaluated for uniformity of 
weight,  thickness,  hardness,  friability,  wetting  time,  water  absorption  ratio,  disintegration  time  and  dissolution  study.  Using  the  same 
excipients, the tablets were prepared, without disintegrants and were evaluated in the similar way. Fromm the result obtained, it can be 
concluded  that  the  tablet  formulation  (batch  B4)  showed  disintegration  time  of  25±2.0  seconds  in  vitro.  The  hardness,  friability  and 
dissolution rate of prepared tablet (batch B4) were found to be acceptable according to standard limits. 
Keyword: Bambuterol hydrochloride, direct compression, superdisintegrants. 
 
INTRODUCTION 
Asthma is caused by inflammation in the airways. When 
an  asthma  attack  occurs,  the  muscles  surrounding  the 
airways become tight and the lining of the air passages 
swells. This reduces the amount of air that can pass by. 
For  the  past  one  decade,  there  has  been  an  enhanced 
demand for more patient-friendly and compliant dosage 
forms. Thus an attempt was made to improve onset of 
action  by  preparing  bronchodilator  used  commonly  in 
treatment of asthma. 
Bambuterol  hydrochloride  (RS)-5-(2-tert-butylamino-1-
hydroxyethyl)-m-phynylene  bis  (dimethylcarbamate) 
hydrochloride  is a direct acting  sympathomimetic with 
predominantly adrenergic activity (β2 agonist). It is an 
ester  pro-drug  of  β2  adrenergic  agonist  terbutaline.  In 
these  research  study,  an  attempt  was  made  to  develop 
mouth  dissolving  tablets  of  Bambuterol  hydrochloride 
with  enhance  dissolution  rate  and  improved  patient 
compliance.
1-4 
MATERIALS AND METHODS 
Bambuterol  HCl  was  procured  from  market, 
Croscarmellose  sodium  (CCS)  used  was  analytical 
reagent  (AR)  grade  procured  from  Loba  Chemie, 
Mumbai and Sodium Starch Glycolate (SSG) used was 
procured  from  Merck  Limited,  Mumbai.  All  other 
reagents and chemicals used were of analytical grade. 
Preparation  of  mouth  dissolving  tablets  of 
Bambuterol HCl 
All the materials were passed through 60 # screens prior 
to  mixing.  Bambuterol  HCl,  croscarmellose  sodium 
(CCS),  Sodium  Starch  Glycolate  (SSG),  and  Mannitol 
were  mixed  using  a  glass  mortar  and  pestle.  All  the 
materials  were  directly  compressible  so  this  uniformly 
mixed blend was compressed into tablets using concave 
face  round  tooling  on  a  Rimek-rotary  tablet  machine
5. 
The composition of the batches is shown in Table 1. 
EVALUATION  OF  MOUTH  DISSOLVING 
TABLETS 
 
The  formulations  were  evaluated  for  weight  variation, 
thickness, content uniformity, drug content (assay) and in 
vitro dissolution studies. 
Weight variation 
Weight  variation  was  done  by  selecting  20  tablets 
randomly  and  weighing  individually.  Average  weight 
was calculated and the weight of individual tablet was 
compared with it
6. All results are given in table 2. 
Thickness 
The  thickness  was  measured  using  vernier  caliper  and 
expressed in mm. All results are given in table 2. 
Friability  
Friability  test  was  performed  using  a  Roche  Friability 
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friction and shocks which may often cause tablet to chip, 
cap or break. This device subjects a number of tablets to 
the combine effect of abrasion and shock by utilizing a 
plastic  chamber  that  revolves  at  25  rpm,  dropping  the 
tablets at the distance of 6 inches with each revolution. 
Pre-weighed tablet sample is placed in friabilator which 
is then operated for 100 revolutions. The tablets are then 
dusted and re-weighed. The % friability was measured 
using following formula
6: 
% F = [(W-Wo)/ Wo ] * 100 
Where, % F = Friability in percentage, W = initial weight 
of tablet, Wo = Weight of tablets after test. All results are 
given in table 2. 
Hardness 
The  strength  of  tablet  is  expressed  as  tensile  strength 
(Kg/cm
2). The tablet crushing  load, which  is the  force 
required to break a tablet into halves by compression. It 
was  measured  using  tablet  hardness  tester  (Monsanto 
hardness tester)
 6. All results are given in table 2. 
Water absorption ratio 
A  piece  of  tissue  paper  folded  twice  was  placed  in  a 
small  petridish  (internal  diameter  =5.8  cm)  containing 
5.5 ml of water. A tablet was placed on the paper and the 
time required for complete wetting was then measured. 
The water absorption ratio (R) was determined using the 
following Equation
6 
Water absorption ratio (R) = [(Wa – Wb) / Wb] * 100 
Where,  Wb  is  the  weight  of  tablet  before  water 
absorption  and  Wa  is  the  weight  of  tablet  after  water 
absorption. All results are given in table 2. 
Disintegration time  
One  tablet  was  placed  in  each  of  six  tubes  of 
disintegration test apparatus. The test was carried out at 
37±2
oC  according  to  USP  XXII.  Disintegration  test 
apparatus  was  used  without  disc.  Time  required  for 
complete disintegration of tablet fragments through sieve 
(#10) was considered as a disintegration time of tablet
6. 
All results are given in table 2. 
In vitro Dissolution studies  
The  in  vitro dissolution study was carried out in USP 
dissolution test apparatus Type II (Electrolab, India). The 
dissolution  medium  consisted  of  phosphate  buffer  (pH 
6.8). An amount of 900 ml of dissolution fluid was used 
at 37±0.5
o C with stirring speed of 50 rpm. Aliquot was 
withdrawn at interval of 2, 4, 6, 8, 10 minutes, at the time 
interval of 2 minute by replacing with same dissolution 
medium  and  samples  were  analyzed  by  measuring  the 
absorbance  at  265  nm  by  UV  spectrophotometer
6 
(Shimadzu 1700). All results are given in table 2. 
 
 
RESULT AND DISCUSSION 
The use of superdisintegrants for preparation of mouth 
dissolving tablets  is  highly  effective and  commercially 
feasible.  The  results  of  tablets  were  evaluated  for 
uniformity  of  weight,  wetting  time,  water  absorption 
ratio,  disintegration  time  and  dissolution  as  show  in 
Table 2. 
Using  the  same  excipients,  the  tablets  were  prepared, 
without these superdisintegrants accelerate disintegration 
of  tablets  by  virtue  of  their  ability  to  absorb  a  large 
amount  of  water  when  exposed  to  an  aqueous 
environment. The absorption of water results in breaking 
of  tablets  and  therefore  faster  disintegration.  This 
disintegration is reported to have an effect on dissolution 
characteristics as well. Prepared mouth dissolving tablet 
gets dispersed in the mouth quickly and releases the drug 
early as compared to its formulated conventional tablet. 
Figure 1 show the cumulative percentage of Bambuterol 
HCl  released  from  formulated  tablet  with  different 
concentration of CCS and SSG. 
It  is  clear  that  the  dissolution  of  Bambuterol  HCl  has 
improved considerably in formulation B4 as compared to 
formulation B1, B2, B3 and B5 .The table of batch B4 
shows good dissolution efficiency and rapid dissolution. 
The study shows dissolution of Bambuterol HCl can be 
enhanced  to  great  extend  by  direct  compression 
technique with the addition of superdisintegrants, which 
give quick relief from asthma.  
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Table 1: Formulation of Bambuterol HCl mouth dissolving tablet 
 
Ingredients  B1  B2  B3  B4  B5 
Bambuterol Hydrochloride   10  10  10  10  10 
Lactose DCL11  70  60  80  80  100 
Pearlitol SD200  130  130  130  130  180 
Croscarmellose sodium  40  50  40  30  - 
Sodium starch glycolate  40  40  30  40  - 
Magnesium stearate  5  5  5  5  5 
Talc  5  5  5  5  5 
Total (mg)  300  300  300  300  300 
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Table 2: Evaluation of Bambuterol HCl mouth dissolving tablet 
 
Batch  Weight 
variation  
Thickness 
(mm) 
Hardness  n=10 
(Kg/cm
2) 
Friability (%)  Wetting time 
(sec.) 
Water 
absorption 
ratio (%) 
Disintegration 
time (sec.) 
B1  299±3.09  4.2  3.2±0.12  0.32  32  78.45  30±2.5 
B2  300±2.98  4.4  3.6±0.15  0.35  37  73.57  31±2.9 
B3  301±1.45  4.3  3.7±0.21  0.29  31  80.12  33±2.1 
B4  298±1.33  4.3  3.5±0.32  0.36  34  90.89  29±2.0 
B5  299±2.06  4.2  3.0±0.27  0.27  61  61.99  58±2.1 
 
 
 
 
Fig 1: Drug release profile of Bambuterol HCl  mouth dissolving tablets of various batch 
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